Literature DB >> 3572366

Immunological interrelationships among human and non-human paramyxoviruses revealed by immunoprecipitation.

Y Ito, M Tsurudome, M Hishiyama, A Yamada.   

Abstract

Antigenic interrelationships among paramyxoviruses were examined by immunoprecipitation of isotope-labelled virus-infected cell lysates with specific antisera against virions or virus components. Sendai virus, human parainfluenza virus type 1 (Pa-1) and human parainfluenza virus type 3 (Pa-3) belonged to one antigenic group, and human parainfluenza virus type 2 (Pa-2), human parainfluenza virus type 4 (Pa-4), mumps virus (MuV) and simian virus 5 to a second group. Furthermore, the human paramyxoviruses Pa-1, Pa-2, Pa-3, Pa-4 and MuV formed a single antigenic group which overlapped the above groups. Although Newcastle disease virus (NDV) belonged to a separate group it showed some cross-reaction with the human paramyxoviruses. In particular, certain batches of anti-NDV antisera reacted with the fusion (F) polypeptide of Pa-2 and the reciprocal reaction of anti-Pa-2 antiserum with NDV F was also found. The nucleoprotein showed the broadest cross-reactions among these paramyxoviruses, whereas the matrix polypeptide exhibited antigenic individuality. The nucleoprotein of MuV was most cross-reactive. Pa-2 haemagglutinin-neuraminidase (HN) and anti-MuV HN serum showed cross-reactivity with various antisera and antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572366     DOI: 10.1099/0022-1317-68-5-1289

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Early stage of establishment of persistent Sendai virus infection: unstable dynamic phase and then selection of viruses which are tightly cell associated, temperature sensitive, and capable of establishing persistent infection.

Authors:  Morihiro Ito; Taijiro Takeuchi; Machiko Nishio; Mitsuo Kawano; Hiroshi Komada; Masato Tsurudome; Yasuhiko Ito
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Immunological relationships between parainfluenza virus type 4 and other paramyxoviruses studied by use of monoclonal antibodies.

Authors:  H Komada; E Klippmark; C Orvell; R E Randall; Y Ito; E Norrby
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein.

Authors:  Y Matsuoka; J Curran; T Pelet; D Kolakofsky; R Ray; R W Compans
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.

Authors:  K van Wyke Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Molecular evolution of human paramyxoviruses. Nucleotide sequence analyses of the human parainfluenza type 1 virus NP and M protein genes and construction of phylogenetic trees for all the human paramyxoviruses.

Authors:  K Miyahara; S Kitada; M Yoshimoto; H Matsumura; M Kawano; H Komada; M Tsurudome; S Kusagawa; M Nishio; Y Ito
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

Review 7.  Pathogen survival in the external environment and the evolution of virulence.

Authors:  Bruno A Walther; Paul W Ewald
Journal:  Biol Rev Camb Philos Soc       Date:  2004-11

8.  Three unique Sendai virus antigenic peptides screened from nucleocapsid protein by overlapping peptide array.

Authors:  Zhiguang Xiang; Wei Tong; Yuhan Li; Chuan Qin; Qiang Wei
Journal:  J Virol Methods       Date:  2013-06-28       Impact factor: 2.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.